Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Medicine  8, 1089 - 1097 (2002)
Published online: 9 September 2002; | doi:10.1038/nm763

Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice

Niall C. Tebbutt1, 5, Andrew S. Giraud2, 5, Melissa Inglese1, Brendan Jenkins1, Paul Waring3, Fiona J. Clay1, Sina Malki2, Barbara M. Alderman2, Dianne Grail1, Frédéric Hollande4, Joan K. Heath1 & Matthias Ernst1

1  Ludwig Institute for Cancer Research, Royal Melbourne Hospital, Parkville, Victoria, Australia

2  Department of Medicine, University of Melbourne, Western Hospital, Footscray, Victoria, Australia

3  Department of Pathology, Peter MacCallum Institute, East Melbourne, Victoria, Australia

4  Laboratoire de Signalisation Cellulaire Normale et Tumorale, Faculté de Pharmacie, Montpellier, France

5  N.C.T. and A.S.G. contributed equally to this study.

Correspondence should be addressed to Matthias Ernst matthias.ernst@ludwig.edu.au
The intracellular signaling mechanisms that specify tissue-specific responses to the interleukin-6 (IL-6) family of cytokines are not well understood. Here, we evaluated the functions of the two major signaling pathways, the signal transducers and activators of transcription 1 and 3 (STAT1/3) and the Src-homology tyrosine phosphatase 2 (SHP2)-Ras-ERK, emanating from the common signal transducer, gp130, in the gastrointestinal tract. Gp130757F mice, with a 'knock-in' mutation abrogating SHP2-Ras-ERK signaling, developed gastric adenomas by three months of age. In contrast, mice harboring the reciprocal mutation ablating STAT1/3 signaling (gp130DeltaSTAT), or deficient in IL-6-mediated gp130 signaling (IL-6-/- mice), showed impaired colonic mucosal wound healing. These gastrointestinal phenotypes are highly similar to the phenotypes exhibited by mice deficient in trefoil factor 1 (pS2/TFF1) and intestinal trefoil factor (ITF)/TFF3, respectively, and corresponded closely with the capacity of the two pathways to stimulate transcription of the genes encoding pS2/TFF1 and ITF/TFF3. We propose a model whereby mucosal wound healing depends solely on activation of STAT1/3, whereas gastric hyperplasia ensues when the coordinated activation of the STAT1/3 and SHP2-Ras-ERK pathways is disrupted.

MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

REVIEWS
Trefoil factors: initiators of mucosal healing
Nature Reviews Molecular Cell Biology Review (01 Sep 2003)
 See all 2 matches for Reviews

NEWS AND VIEWS
Inflammation intersection: gp130 balances gut irritation and stomach cancer
Nature Medicine News and Views (01 Oct 2002)

RESEARCH
Expression of Cytoplasmic TFF2 Is a Marker of Tumor Metastasis and Negative Prognostic Factor in Gastric Cancer
Laboratory Investigation Article (01 Sep 2003)
Selective abrogation of the proinvasive activity of the trefoil peptides pS2 and spasmolytic polypeptide by disruption of the EGF receptor signaling pathways in kidney and colonic cancer cells
Oncogene Original Article (17 Jul 2003)
Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1
Oncogene Original Article (24 Jun 1999)
 See all 6 matches for Research

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

naturejobs

Figures & Tables
See also: News and Views by Wang & Goldenring
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2002 Nature Publishing Group | Privacy policy